share_log

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

远程健康市场消息:布拉夏科学通过收购佛罗里达州的氯胺酮治疗平台进入行业
Benzinga Real-time News ·  2022/08/03 14:54
A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp. (OTC:BRAXF) has completed the acquisition of the issued and outstanding stock of U.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by providing access to technology-mediated ketamine treatments.
一名研究人员和精神健康疾病氯胺酮辅助治疗的提供者,布拉夏科学公司(场外交易代码:BRAXF)已完成收购已发行及已发行的总部位于美国的私人远程医疗公司KetaMD Inc.,目的是通过提供获得技术介导氯胺酮治疗的机会来解决精神健康问题。
Founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel along with mindfulness instructor Kaia Roman and president and COO Leann Taylor, KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across...
由迷幻先驱创立扎皮·扎波林和沃伦·古佩尔与正念导师一起卡亚·罗曼总裁和首席运营官莉安·泰勒Ket...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发